MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 58.6 ¤711,996 NL
RO.CH Roche Holding Ltd 63.9 ¤330,806 CH
HSBA.GB HSBC Holdings Plc 45.1 ¤325,199 GB
AZN.GB AstraZeneca PLC 59.6 ¤276,593 GB
NOVN.CH Novartis AG 50.0 ¤276,245 CH

Five Smallest Companies
Symbol Name Grade Market Cap Country
CARL.B.DK Carlsberg AS Class B 53.2 ¤17,196 DK
HAL.NL HAL Trust 64.4 ¤17,422 NL
BOL.SE Boliden AB 62.9 ¤17,474 SE
STMN.CH Straumann Holding AG 52.7 ¤18,751 CH
STE STERIS plc 65.8 ¤20,126 IE

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 58.6 34 NL
ACN Accenture Plc Class A 63.8 33 IE
DNB.NO DNB Bank ASA 51.5 30 NO
ALV.DE Allianz SE 54.0 29 DE
LR.FR Legrand SA 57.5 29 FR
NOVO.B.DK Novo Nordisk A/S Class B 76.4 29 DK
TEL TE Connectivity plc 68.3 27 IE
ETN Eaton Corp. Plc 55.2 26 IE
MUV2.DE Munchener Ruckversicherungs-Gesellschaft 51.2 26 DE
SAND.SE Sandvik AB 51.9 25 SE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤84,831
Median Market Cap ¤52,325
Avg. 3 Mo. Dollar Vol. ¤210,637,816
Avg. 3 Mo. Trading Vol. 4,181,800
Last Rebalance Date 03/23/2026
Companies Replaced 38
Biggest Sector Increase Industrials
Biggest Sector Decrease Health Care

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 18.0
Forward P/E Ratio (12 Mo.) 15.6
Price/Book Ratio 3.6
Avg. Revenue Chg. - 3 Yr 22.7%
Avg. Op. Income Chg. - 3 Yr. 45.4%
Avg. EPS Growth - 3 Yr. 16.1%
Avg. EPS Growth - 1 Yr. 15.8%
Avg. Operating Margin 19.7%
Avg. LT Debt to Total Capital 41.7%
Avg. Return on Equity 18.6%
Dividend Yield 2.1%
Index Average Grade
Europe 100 Index 57.53
Country Breakdown
United Kingdom 19.0%
Ireland 12.0%
Switzerland 11.0%
Germany 11.0%
Italy 8.0%
France 8.0%
Netherlands 8.0%
Sweden 8.0%
Spain 4.0%
Denmark 3.0%
Finland 2.0%
Luxembourg 2.0%
Austria 2.0%
Norway 1.0%
United States Of America 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE